HeimGNGBY • OTCMKTS
add
Getinge ADR
Við síðustu lokun
22,33 $
Dagbil
21,95 $ - 22,11 $
Árabil
17,70 $ - 24,67 $
Markaðsvirði
49,66 ma. SEK
Meðalmagn
2,34 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (SEK) | des. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 10,19 ma. | -7,99% |
Rekstrarkostnaður | 3,39 ma. | 0,00% |
Nettótekjur | 868,00 m. | 30,72% |
Hagnaðarhlutfall | 8,52 | 42,00% |
Hagnaður á hvern hlut | 4,45 | -15,72% |
EBITDA | 1,80 ma. | -9,45% |
Virkt skatthlutfall | 28,00% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (SEK) | des. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 3,40 ma. | 14,86% |
Heildareignir | 56,50 ma. | -11,60% |
Heildarskuldir | 27,01 ma. | -12,04% |
Eigið fé alls | 29,49 ma. | — |
Útistandandi hlutabréf | 272,37 m. | — |
Eiginfjárgengi | 0,21 | — |
Arðsemi eigna | 6,22% | — |
Ávöxtun eigin fjár | 8,68% | — |
Peningaflæði
Breyting á handbæru fé
| (SEK) | des. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 868,00 m. | 30,72% |
Handbært fé frá rekstri | 1,55 ma. | -23,79% |
Reiðufé frá fjárfestingum | -447,00 m. | 13,04% |
Reiðufé frá fjármögnun | -625,00 m. | -20,19% |
Breyting á handbæru fé | 554,00 m. | -23,06% |
Frjálst peningaflæði | 1,54 ma. | 40,35% |
Um
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the Chairman of the Board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
Framkvæmdastjóri
Stofnsett
1904
Vefsvæði
Starfsfólk
11.670
